Malignant Eccrine Spiradenoma

Chapter
First Online:

Abstract

Malignant eccrine spiradenoma (MES) is an extremely rare aggressive tumor, firstly reported in 1972 by Dabska that can occur de novo or more commonly arise on a preexisting often long-standing eccrine spiradenoma. The latency period before malignant transformation ranges from 6 months to 70 years. To date, about 102 cases have been reported, mostly as single case report.

Keywords

Eccrine spiradenocarcinoma Malignant spiradenoma 
This is a preview of subscription content, log in to check access.

Bibliography

  1. Andreoli MT, Itani KM. Malignant eccrine spiradenoma: a meta-analysis of reported cases. Am J Surg. 2011;201:695–9.PubMedCrossRefGoogle Scholar
  2. Ben Brahim E, Sfia M, Tangour M, Makhlouf R, Cribier B, Chatti S. Malignant eccrine spiradenoma: a new case report. J Cutan Pathol. 2010;37:478–81.PubMedCrossRefGoogle Scholar
  3. Carlsten JR, Lewis MD, Saddler K, Reilly P, Pan T, Gnepp DR, Robinson-Bostom L. Spiradenocylindrocarcinoma: a malignant hybrid tumor. J Cutan Pathol. 2005;32:166–71.PubMedCrossRefGoogle Scholar
  4. Chase DM, Basu T, Saffari B, Ries S, Berman ML. Malignant eccrine spiradenoma of the vulva: a case report and review of the literature. Int J Gynecol Cancer. 2006;16:1465–9.PubMedCrossRefGoogle Scholar
  5. Dabska M. Malignant transformation of eccrine spiradenoma. Pol Med J. 1972;11:388.PubMedGoogle Scholar
  6. Granter SR, Seeger K, Calonje E, Busam K, McKee PH. Malignant eccrine spiradenoma (spiradenocarcinoma): a clinicopathologic study of 12 cases. Am J Dermatopathol. 2000;22:97–103.PubMedCrossRefGoogle Scholar
  7. Ishikawa M, Nakanishi Y, Yamazaki N, Yamamoto A. Malignant eccrine spiradenoma: a case report and review of the literature. Dermatol Surg. 2001;27:67–70.PubMedGoogle Scholar
  8. Mirza I, Kloss R, Sieber SC. Malignant eccrine spiradenoma. Arch Pathol Lab Med. 2002;126:591–4.PubMedGoogle Scholar
  9. Seyhan T, Borman H, Bal N. Malignant eccrine spiradenoma of the scalp. J Craniofac Surg. 2008;19:1608–12.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Department of Surgical PathologyFatebenefratelliMilanItaly
  2. 2.Section of Dermatology, Department of Health Sciences and Division of PathologyUniversity of GenovaGenovaItaly

Personalised recommendations